Ukoniq Side Effects Linked to Increased Risk of Death, FDA Warns, Withdraws Drug Approval
The FDA has withdrawn approval for the lymphoma drug Ukoniq after determining the risk of death outweighs any potential benefits.
The FDA has withdrawn approval for the lymphoma drug Ukoniq after determining the risk of death outweighs any potential benefits.
The FDA warns that the relatively new cancer drug, Ukoniq, may increase the risk of death in the lymphoma patients it was designed to treat.
Coppertone is recalling 12 lots of aerosol sunscreen products due to high levels of benzene, which can cause adverse health effects, including cancer and anemia.
A new study warns that fracking operations may release cancer-causing chemicals into the air and water, potentially increasing the risk of cancer and childhood leukemia in nearby communities.
Two new Roundup lawsuits have been filed by agricultural workers who say they developed cancer after being exposed to the Monsanto herbicide.
Federal drug regulators are warning that the lymphoma drug Adcetris has been linked to potentially lethal brain infections and a risk of serious lung problems.
Federal drug regulators are warning that patients taking Enbrel, Humira and other similar drugs continue to report incidents of Hepatosplenic T-Cell Lymphoma, which could be related to the drugs’ suppression…
Frequent and long-term users of acetaminophen may face an increased risk of blood cancer, according to new research.
Federal drug regulators are receiving an increasing amount of blood cancer reports from users of some drugs designed to treat inflammatory bowel disease (IBD).
Two organizations representing plastic surgeons have removed information from their websites that some critics say was telling their members to downplay the risk of that cancer may be caused by…